XML 38 R22.htm IDEA: XBRL DOCUMENT v3.24.0.1
WARRANTS
12 Months Ended
Dec. 31, 2023
Other Liabilities Disclosure [Abstract]  
WARRANTS WARRANTS
As of December 31, 2023, the Company had issued outstanding warrants to purchase shares of its Class A common stock as follows:
Issue DateNumber of Warrants OutstandingCommencement DateTermination DateExercise PriceValue at Grant Date (In Thousands)
06/19/201946,875 12/24/202006/19/2024$7.27  N/A (1)
10/03/201960 10/03/201910/03/2024$7.73 $— 
07/16/2020982,855 12/24/202007/16/2025$3.76 $1,163 
07/16/202018,648 12/24/202007/16/2025$3.76 $64 
1,048,438 
(1)
Values were not calculated at the issue date because the warrants were only exercisable in the event of a merger involving the Company and FCCG.
In addition to the warrants to purchase common stock described above, the Company has also granted warrants issued on July 16, 2020, to purchase 3,600 shares of the Company’s Series B Preferred Stock at an exercise price of $24.95 per share, exercisable beginning on the earlier of one year from the date of issuance, or the consummation of a merger or other similar business combination transaction involving the Company and FCCG, and will expire on July 16, 2025.
The Company’s activity in warrants to purchase Class A common stock for the fiscal year ended December 31, 2023 was as follows:
Number of
Shares
Weighted
Average
Exercise Price (1)
Weighted
Average
Remaining
Contractual
Life (Years)
Warrants outstanding at December 25, 20221,591,256 $3.88 2.4
Exercised(342,290)$2.99 1.5
Expired(200,528)$7.06 — 
Warrants outstanding at December 31, 20231,048,438 $2.95 1.6
Warrants exercisable at December 31, 20231,048,438 $2.95 1.6
(1)Exercise price adjusted due to cash dividends and Class B stock dividend.
The Company’s warrant activity for the fiscal year ended December 25, 2022 was as follows:
Number of
Shares
Weighted
Average
Exercise Price
Weighted
Average
Remaining
Contractual
Life (Years)
Warrants outstanding at December 26, 20211,707,670 $4.72 3.2
Exercised(34,714)$3.57 2.6
Cancelled(81,700)$13.35 — 
Warrants outstanding at December 25, 20221,591,256 $3.88 2.4
Warrants exercisable at December 25, 20221,591,256 $3.88 2.4
During the fiscal year ended December 31, 2023, a total of 342,290 warrants were exercised in exchange for 342,290 shares of common stock with net proceeds to the Company of $0.7 million.
The range of assumptions used to establish the initial value of the warrants using the Black-Scholes valuation model were as follows:
Warrants
Expected dividend yield
4.00% - 6.63%
Expected volatility
30.23% - 31.73%
Risk-free interest rate
0.99% - 1.91%
Expected term (in years)
3.8 - 5.0